Calidi Biotherapeutics, Inc. (CLDI)
0.6993
+0.02
(+2.99%)
USD |
NYAM |
Nov 06, 10:22
Calidi Biotherapeutics EPS Diluted (Quarterly) : -2.938 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.938 |
| March 31, 2026 | -6.856 |
| December 31, 2025 | -8.992 |
| September 30, 2025 | -35.29 |
| June 30, 2025 | -31.78 |
| March 31, 2025 | -0.1841 |
| December 31, 2024 | -37.89 |
| September 30, 2024 | -0.0646 |
| June 30, 2024 | -1.396 |
| March 31, 2024 | -2.032 |
| December 31, 2023 | -2.317 |
| Date | Value |
|---|---|
| September 30, 2023 | -1.414 |
| June 30, 2023 | -2733.70 |
| March 31, 2023 | -1433.51 |
| December 31, 2022 | -1734.85 |
| September 30, 2022 | -1200.29 |
| June 30, 2022 | 1.447 |
| March 31, 2022 | 0.5086 |
| December 31, 2021 | 1.493 |
| September 30, 2021 | -0.2864 |
| June 30, 2021 | -0.0035 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.16M |
| Total Expenses (Quarterly) | 4.16M |
| Enterprise Value | -0.9339M |
| Earnings Yield | -7.73K% |
| Normalized Earnings Yield | -7726.24 |